Critical tests and safety studies on trichlorfon as an antiparasitic agent in the horse.

Three series of critical tests were completed on a combined total of 46 horses to determine the efficacy of single doses of trichlorfon against bots, ascarids, pinworms, and large strongyles. Different formulations of trichlorfon were administered by tubing intragastrically, mixing with the daily grain ration, injecting intramuscularly, or pouring on the back at dose rates between 20 and 100 mg/kg. Administration by feeding tended to be more efficacious for removal of bots and less toxic to the horese than administration by stomach tube. In many of the tests, trichlorfon was given in the grain ration at the dose rate of 40 mg/kg of body weight, and the aggregate average removals of 2nd and 3rd instars of Gastrophilus intestinalis and Gasterophilus nasalis in the 3 series of tests were between 97 and 100%. Removal of Parascaris equorum was equally efficacious with both the intubation and the grain feeding methods of dosing, and at the dose rate of 40 mg/kg, the aggregate averages were 99 and 100% in the 3 series. Removal of Oxyuris equi was variable--aggregate averages were between 11 (1 infected horse in the initial series) and 96 (5 infected horses in the 3rd series) to 100% (7 infected horses in the 2nd series). Large strongyles, Strongylus vulgaris and Strongylus edentatus were almost completely refractory to the 40-mg/kg dose rate of trichlorfon. Dose rates of 40 mg/kg and less were generally well tolerated by the critical test horses. Higher dose rates (60 and 80 mg/kg) administered by stomach tube induced moderately severe to severe colic and diarrhea, whereas a dose of 80 mg/kg given in the feed resulted in only a transient softening of the feces. Likewise, 5 consecutive doses, 1 week between doses, of a bolus formulation given at the rate of 80 mg/kg to 4 horses were well tolerated. Clinical trials involving a total of 2,294 treatments of trichlorfon at dose rate of 35 to 40 mg/kg in pregnant and nonpregnant mares, stallions, suckling and weanling foals, yearlings, and horses in training on 38 farms in central Kentucky did not cause notable adverse clinical effects.     

Critical and controlled tests of activity of moxidectin (CL 301,423) against natural infections of internal parasites of equids.

The activity of moxidectin was evaluated in 1988 and 1989 against natural infections of internal parasites in 20 critical tests (n = 20 equids) and three controlled tests (n = 20 equids). Two formulations, injectable administered intramuscularly (i.m.) or intraorally (i.o.) and gel i.o., were given at dose rates of 0.2, 0.3 or 0.4 mg kg-1 body weight. For the critical tests (all three dose rates evaluated), removals of second instar Gasterophilus intestinalis were 93-100%, except (89%) for the injectable formulation (i.m.) at 0.2 mg kg-1. Removals of third instar G. intestinalis were 88-100% for the injectable formulation given i.m. or i.o. and 93-100% for the gel formulation, except (53%) for one batch (0.4 mg kg-1). Activity was 100% for third instar Gasterophilus nasalis, Parascaris equorum, Strongylus vulgaris and Strongylus edentatus. For Oxyuris equi, removals were 91-100%, except (27%) for one batch of the injectable formulation given i.o. at 0.3 mg kg-1. There was apparent activity against migrating S. vulgaris and S. edentatus at various dose rates and routes of administration for both formulations. At necropsy, there were local reactions observed at the injection site of three equids. In the controlled tests, dose rates were 0.2 or 0.4 mg kg-1. Removal of third instar G. intestinalis was highest for the injectable formulation given i.m. All formulations and dose rates were highly effective against S. vulgaris and S. edentatus, but variable and incomplete against O. equi. Removal was excellent on Habronema muscae and on migrating S. vulgaris and S. edentatus, although incomplete on S. vulgaris. Gasterophilus nasalis third instars and P. equorum were present in low numbers in some non-treated equids, but none were recovered from treated equids. Toxicosis was not evident.     

Prevalence of some internal parasites recovered at necropsy of Thoroughbreds born in 1982 in Kentucky

A total of 89 Thoroughbreds, 14 to 333 days old (born in 1982), were examined at necropsy for certain internal parasites during a 1-year-period, Mar 1, 1982, to Feb 28, 1983. The eyes of 73 of the horses and the cranial mesenteric arteries of 71 were examined. Specific interest was on prevalence of parasites according to month of the year and age of the horses at necropsy. Parasites recovered (first month-last month infected horse found) were as follows: Thelazia lacrymalis (eyes) immature and mature (June - February); Habronema/Draschia (lungs) immature (May - September); Habronema muscae (stomach) immature (July - February) and mature (September - February); Draschia megastoma (stomach) immature (August - December), mature (August - February), and lesions (September - February); Gasterophilus intestinalis (stomach) 2nd instars (July - February) and 3rd instars (August - February); Gasterophilus nasalis (stomach) 2nd instars (August - November) and 3rd instars (August - February); Parascaris equorum (lungs) immature (March - November), P equorum (small intestine) immature (March - February), and mature (July - February); Strongyloides westeri (small intestine) mature (March - September); Anoplocephala perfoliata (cecum) immature and mature (August - February); Strongylus vulgaris (cranial mesenteric artery) immature and mature (May - February). Other parasites recovered, but only from 1 or 2 horses each (months found in infected horses) were: Thelazia skrjabini (eyes) (October), Dictyocaulus arnfieldi (lungs) (January); Trichostrongylus axei (stomach) (October); Anoplocephala magna (small intestine) (October, November); S vulgaris (cecum) (November); Strongylus edentatus (cecum) (January); Setaria spp (abdominal cavity) (January). Influence of probable chemotherapy of the horses on prevalence of the parasites is discussed.     

Occurrence of second and third instars of Gasterophilus intestinalis and Gasterophilus nasalis in stomachs of horses in Kentucky.

The occurrence of 2nd and 3rd instars of Gasterophilus intestinalis and Gasterophilus nasalis was determined in 476 horses during the 22-year period from 1951 to 1973. Overall, G intestinalis infected 98.7% of the horses and averaged 168/horse; whereas G nasalis infected 80.7% of the horses and averaged 52/horse. Aggregate average total numbers for G intestinalis ranged from a low of 50 in September to a high of 229 in March, and for G nasalis, from a low of 14 in September to a high of 82 in February. Horses were infected by 2nd or 3rd instars of both species on a year-round basis. Differentiation between the instars provided insight into the dynamics of the infections. For G intestinalis, the data indicated (1) 2nd instars from the previous year's generation of flies continue to arrive in the stomach until April; (2) arrival of the current year's crop of 2nd instars starts in July; and (3) 3rd instars from the previous year's generation of flies are not voided in appreciable numbers until August, when numbers of the current year's crop of 3rd instars appear in the stomach. For G nasalis, the data indicated (1) arrival in the stomach of the current year's generation of 2nd instars starts in July and terminates in January and (2) 3rd instars from the previous year's generation of flies are voided over a period beginning in March and extending into August, when the current year's crop of 3rd instars begin to appear. Acquisition of infections of horses with G intestinalis is nearly a year-round process, except for April, because of the persistence of viable larvae in eggs for a prolonged period after development and fly activity has ceased in the fall. In contrast, infection with G nasalis is interrupted between December and May, because eggs hatch naturally after a short period of development, and fly activity ceases in the fall.     

Critical tests of morantel-trichlorfon paste formulation against internal parasites of the horse

Critical tests were completed on six horses to evaluate the antiparasitic activity of a paste formulation mixture of morantel citrate and trichlorfon, administered intraorally at the dose rate of 6 mg morantel base kg-1 and trichlorfon at 30 mg kg-1. Aggregate average removals were: 78% for two horses infected with 2nd instar Gasterophilus intestinalis; 100% for one infected with 2nd instar G. nasalis; 96% for six infected with 3rd instar G. intestinalis; 100% for four infected with 3rd instar G. nasalis; 100% for five infected with Parascaris equorum; 100% for one infected with mature Oxyuris equi; 100% for five infected with Strongylus vulgaris; 72% for five infected with S. edentatus; and partial removal (25%) of Anoplocephala perfoliata infection from one infected animal. Pre- and post-treatment EPG and LPG data indicated a reduction of 97% of the mature small strongyle infections. Evidence of toxicosis was not observed in any of the horses.     

The anthelmintic efficacy of cambendazole in horses

The anthelmintic activity of cambendazole 31% paste was evaluated in a controlled trial against naturally acquired gastro-intestinal parasites of the horse. Four groups of five adult horses were treated at dose rates of 0, 15, 20 and 25 mg/kg. The three dose levels of cambendazole tested were efficacious against the large strongyles Strongylus edentatus and S. vulgaris, the stomach worm Trichostrongylus axei, the pinworms Oxyuris equi and Probstmayria vivipara and all the species of small strongyles present. No efficacy was demonstrated against the tapeworm Anoplocephala perfoliata or the horse bots Gasterophilus intestinalis or G. nasalis     

Prevalence of internal parasites in horses in critical tests of activity of parasiticides over a 28-year period (1956-1983) in Kentucky

The prevalence and number of naturally acquired gastrointestinal parasites were compiled for horses used in critical tests of activity of parasiticides over a 28-year period (1956-1983). Data are presented as follows: n = number of horses examined; % = mean prevalence; number in parentheses after % = aggregate mean number of parasites in infected horses. Parasites found were: bots (n = 513) - Gasterophilus intestinalis, 2nd instar, 61%(58); 3rd instar, 94%(168); G. nasalis, 2nd instar, 36%(28); 3rd instar, 81%(51); stomach worms (n = 200) - Habronema muscae, 65%(179); Draschia megastoma, 29%(95); Trichostrongylus axei, 46%(3000); ascarids (n = 513) - Parascaris equorum, mature, 50%(25); immature, 23%(33); tapeworms (n = 513), Anoplocephala perfoliata, 17%(15); A. magna, 14%(10); large strongyles (n = 487), Strongylus vulgaris, 84%(80); S. edentatus, 79%(101); S. equinus, 6%(14); small strongyles (n = 210), 100%(142,000); pinworms (Oxyuris equi), immature (n = 210), 78%(9000); mature (n = 506), 40%(62); Probstmayria vivipara (n = 210), 12%(10(7]; S. vulgaris in cranial mesenteric artery (n = 472), 89%(57). The majority of the horses examined were mixed lighthorse type but several Thoroughbreds were included. Ages varied from about 4 months to 20 years old, with most being approximately 1-3 years old. They probably had either no or infrequent previous treatment with parasiticides. Most of the horses were selected for presence of certain internal parasites, usually large strongyles, prior to usage in the critical tests.     

Prevalence of some internal parasites found (1971–1989) in horses born on a farm in central kentucky

Prevalence of several species of naturally acquired internal parasites are reported from a total of 97 horses (mostly mixed lighthorse type) from a farm in central Kentucky. The horses were born and raised in 2 adjacent fields (No. 4 - n=44 and No. 10 − n=53) over a 19-year-period (1971–1989). They were 100 to 537 days old (av. 281) when examined; an exception was a 819-day-old not calculated in the average age. Some of the horses were not examined for all of the parasites. These horses (never previously treated) were all used in critical or controlled tests for evaluation of antiparasitic activity of drugs. Dams and other horses in the fields rarely were given an antiparasitic compound.Prevalence and aggregate mean numbers of parasites in infected animals (in parentheses) for the 97 horses are: bots — Gasterophilus intestinalis 2nd instar, 65%(45), 3rd instar, 96%(210), Gasterophilus nasalis 2nd instar, 18%(10), 3rd instar, 63%(10); stomach worms — Habronema muscae, 73%(78), Draschia megastoma, 42%(53); ascarids — Parascaris equorum mature, 75%(45), immature 36%(29), tapeworms — Anoplocephala perfoliata, 33%(7); large strongyles — Strongylus vulgaris, 95%(80) (data on horses ≥180 days old), Strongylus edentatus, 94%(34) (data on horses ≥330 days old); pinworms — Oxyuris equi, 43%(87); eyeworms — Thelazia lacrymalis, 61%(6); S. vulgaris in cranial mesenteric artery, 92%(53); and S. edentatus in ventral abdominal wall, 98% (56). Differentiation was made for the data by season and by age of the horses when they were examined. Information from this research reflects the transmission patterns and prevalence of these parasites under natural conditions.     

Prevalence of selected species of internal parasites in equids at necropsy in central Kentucky (1995-1999)

A survey to determine current prevalence of several species of endoparasites in equids (n=350) at necropsy was conducted at the Livestock Disease Diagnostic Center in central Kentucky (1995-1999). Thelazia lacrymalis were found in 42% of the 1- to 4-year olds (n=132), which was the only age group examined for these parasites. Five- to 30-year olds (n=157), examined for Onchocerca spp. worms/lesions, had a prevalence of 24%. In > or =1-year olds (n=324), the infection rate for Gasterophilus intestinalis was 12% for second instars and 14% for third instars and for Gasterophilus nasalis was 2% for second instars and 2% for third instars. For Anoplocephala perfoliata (n=268 equids), prevalence was 52%. Data were compiled for the equids according to breed, age, sex, month of necropsy, and number of parasites. Arterial lesions caused by migrating Strongylus vulgaris larvae were observed in a low number (3 of 52) of equids. Specific examination for Parascaris equorum revealed that 46% of 13 weanlings and 10% of 20 older horses were infected. Anoplocephala magna were found in one of the weanlings. Compared to previous studies (about 15-25 years ago) in Kentucky, the present survey indicated the genera Onchocerca and Gasterophilus greatly declined but Thelazia, Anoplocephala, and Parascaris did not.     

World association for the advancement of veterinary parasitology (WAAVP): second edition of guidelines for evaluating the efficacy of equine anthelmintics.

These guidelines have been designed to assist in the planning, operation and interpretation of studies which would serve to assess the efficacy of drugs against internal parasites of horses. Although the term anthelmintic is used in the title and text, these guidelines include studies on drug efficacy against larvae of horse bot flies, Gasterophilus spp., which are non-helminth parasites commonly occurring in the stomach of horses. The advantages, disadvantages and application of critical and controlled tests are presented. Information is also provided on selection of animals, housing, feed, dose titration, confirmatory and clinical trials, record keeping and necropsy procedures. These guidelines should assist both investigators and registration authorities in the evaluation of compounds using comparable and standard procedures with the minimum number of animals.     

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of equine anthelmintics

These guidelines have been designed to assist in the planning, operation and interpretation of studies which would serve to assess the efficacy of drugs against internal parasites of horses. Although the term anthelmintic is used in the title and text, these guidelines include studies on drug efficacy against larvae of horse bot flies, Gasterophilus spp, which are non-helminth parasites commonly occurring in the stomach of horses. The advantages, disadvantages and application of critical and controlled tests are presented. Information is also provided on selection of animals, housing, feed, dose titration, confirmatory and clinical trials, record keeping and necropsy procedures. These guidelines should assist both investigators and registration authorities in the evaluation of compounds using comparable and standard procedures with the minimum number of animals.     

The antiparasitic activity of ivermectin in horses

Parenteral administration of ivermectin (22,23-dihydroavermectin B₁) significantly reduced the numbers of adult large and small strongyles, the immature stages of small strongyles, pinworm and ascarid, the microfilariae of Onchocerca cervicalis and gastrophilid bots from naturally infected horses. Strongylus vulgaris, S. edentatus and S. equinus were effectively removed by 0.02 mg/kg. Adult small strongyles, Cyathostomum pateratum, C. catinatum, Cylicocyclus nassatus, C. leptostomus, Cyliostephanus minutus, C. longibursatus and C. goldi, were effectively removed by 0.1 mg/kg. Fourth stage small strongyles (cyathostomes), 4th stage Oxyuris equi, 5th stage Parascaris equorum and the microfilarie of Onchocerca cervicalis were significantly reduced by 0.1 mg/kg also. The stomach bots, Gastrophilus intestinalis and G. nasalis, were effectively removed by 0.02 mg of ivermectin/kg. Analysis of the dose response curves obtained for the nematode and larval dipteran parasites found in these naturally infected horses suggests that a parenteral dose of 0.2 mg/kg ivermectin would produce 95% or more removal of these parasites. The antiparasitic efficacies observed for ivermectin in this controlled trial were equivalent to the efficacies found in an abbreviated critical trial contained within the controlled trial. However, it was calculated that the man—day effort required for data collection from one critical trial horse was the same as for 6 controlled-trial horses.     

马胃蝇蛆病造成马体损伤性研究

本研究采用尸检方式探究马胃蝇寄生对马体所造成的伤害。结果发现,马胃蝇幼虫在马体内的寄生部位是随着虫龄的增加逐渐向消化道末端移动,直至幼虫发育成熟排出体外,没有明显的逆向移动现象;虫态期最长的3龄幼虫(L3)在寄生部位选择上存在着种间差异性,黑角胃蝇和鼻胃蝇在幽门口外的十二指肠前端,黑腹胃蝇和红尾胃蝇寄生于胃部;马科动物个体感染马胃蝇的数量与被检马匹的年龄(P=0.320)和性别(P=0.665)没有必然联系;马胃蝇蛆病在当地马科动物间普遍发生,胃部损伤面积达60%~80%,其中,野马感染马胃蝇数量最高,其次是野驴和家马。研究结果有助于加深对胃蝇属昆虫危害的认识及再引入野马健康状况的掌握,对于野马保护意识的加强以及强化后续监管工作提供了强有力的支持。     

Common internal parasites found in the stomach, large intestine, and cranial mesenteric artery of thoroughbreds in Kentucky at necropsy (1985 to 1986)

A total of 278 Thoroughbreds (less than 1 to 31 years old) were examined at necropsy (July 9, 1985, to Feb 2, 1986) in Kentucky for various internal parasites. Examination was not made of all the horses for each of the parasites. Specific parasites recovered from the stomach of foals (n = 30) and yearlings and older horses (n = 96) and percentage (in parentheses) of each age category infected, respectively, were as follows: Gasterophilus intestinalis 2nd instar (53% and 32%) and 3rd instar (37% and 24%); G nasalis 2nd instar (7% and 8%) and 3rd instar (7% and 10%); Habronema spp immature (7% and 13%); H muscae (3% and 8%); Draschia megastoma (3% and 5%) and lesions (0% and 2%); and Trichostrongylus axei (0% and 3%). Parasites in the large intestine included Anoplocephala perfoliata, which was found in the cecum of 30% of the foals (n = 87) and in 60% of the yearlings and older horses (n = 186). Probstmayria vivipara and immature Oxyuris equi were not found in the colon and rectum of any of the horses (n = 53 foals and n = 101 yearlings and older); mature O equi were not sought. Examination of the cranial mesenteric artery for Strongylus vulgaris revealed immature and/or mature specimens in 9% of foals (n = 87) and 14% of yearlings (n = 44); lesions of S vulgaris were present in 25% of foals (n = 87) and 34% of yearlings (n = 44).     

Efficacy of ivermectin (22,23-dihydroavermectin B1) against gastrointestinal parasites in ponies

The controlled test method was used to evaluate the antiparasitic efficacy of IM inoculated 22,23-dihydroavermectin B1 (ivermectin) against gastrointestinal parasites of horses (ponies). Parasite infections were naturally acquired in southern Louisiana. Dose levels of the drug tested were 0.2 mg/kg, 0.3 mg/kg, and 0.5 mg/kg. Ivermectin at all dose levels tested had an efficacy greater than 97% (P less than 0.05) against Gasterophilus intestinalis larvae, Trichostrongylus axei, Oxyuris equi larvae, Strongylus vulgaris, S edentatus, 15 species of small strongyles, and small strongyle larvae. Ponies were less uniformly infected with Habronema sp larvae, G nasalis larvae, Parascaris equorum, O equi adults, Anoplocephala perfoliata, S equinus, and 11 small strongyle species, and statistical analysis was not possible to do. However, observations indicate that the drug was also highly effective against these species. There were no gross or clinical reactions observed in treated animals. Dissections of the injection sites revealed spindle-shaped lesions, 3 to 5 cm long, in a few ponies in all treatment groups, including those given the placebo injection.     

Seasonal occurrence and distribution of Gasterophilus intestinalis and Gasterophilus nasalis in the stomachs of equids in Texas

Stomachs of 271 horses and ponies from 2 sources were evaluated for the presence of Gasterophilus intestinalis and G nasalis larvae, through 2 overlapping 12-month periods of bot fly activity in southern Texas. Equids (n = 140) from one source had nearly 96% of their stomachs infected, whereas equids (n = 131) from another source had 44% of their stomachs infected by Gasterophilus spp. Seasonal dynamics of the bot infection indicated the highest average number of bot larvae per infected stomach occurred in the winter and spring. The smallest average number of bots per infected stomach occurred in the fall. Higher percentages of early (2nd instar plus young 3rd instar) larvae of G intestinalis were observed in the fall in equids from both sources. The late (more fully developed older 3rd instar) G intestinalis larvae outnumbered the early larvae in the winter, spring, and summer. Seasonal variation in numbers and development status of the larvae was consistent with the largest period of adult bot fly activity occurring during the fall. The 2 species of bots had different predilection sites of attachment. Gasterophilus intestinalis larvae concentrated in the nonglandular portions of the stomach near the margo plicatus on the cranial (parietal) surface of the stomach and in the most dorsal extent of the saccus cecus. Gasterophilus nasalis larvae attached almost exclusively in the first ampulla of the duodenum. Predilection sites for both Gasterophilus spp occurred in dorsally positioned areas in the alimentary tract favoring increased availability of oxygen.     

Critical test and safety evaluations of an oral paste preparation of mebendazole and trichlorfon in horses

Critical tests were done on 24 naturally parasitized horses to compare the antiparasitic activity of an oral paste preparation of mebendazole and trichlorfon with that of the marketed powder formulation. Each formulation was administered at the recommended dosages of 8.8 mg of mebendazole and 40 mg of trichlorfon/kg of body weight. Efficacy of the paste formulation ranged from 97.7% to 100% against 2nd- and 3rd-stage Gasterophilus spp, adult Strongylus vulgaris, S edentatus, Parascaris equorum, small strongyles; and larval and adult forms of Oxyuris equi. Adverse effects were generally limited to slight softening of the feces. Mild and transient restlessness or sweating were also observed in 2 of 12 horses treated with the paste formulation. The toxic effects of the paste, administered at 2.2 times the therapeutic dose, were examined in 6 horses and compared with the effects of a nonmedicated paste, administered in similar volumes to 6 other horses. Drug-related changes were not detected in clinical chemical analyses, hematologic values, or liver function tests. Transient clinical signs of organophosphate toxicosis (primarily the passage of loose feces) and prolonged inhibition of erythrocyte cholinesterase activity were evident within 1 hour after drug treatment. These effects were similar to those reported for the 2.2 X dose of marketed powder formulation.     

Efficacy of moxidectin equine oral gel against endoscopically-confirmed Gasterophilus nasalis and Gasterophilus intestinalis (Diptera: Oestridae) infections in horses

A 3 m, video gastroscope was used to screen 47 horses suspected of being naturally infected with equine bot larvae. 17 of 47 (36.2%) candidate horses harbored Gasterophilus nasalis larvae in the proximal duodenum and 46 of 47 (97.9%) had G. intestinalis larvae in the stomach. All horses infected with G. nasalis had concurrent infections with G. intestinalis. 14 horses with dual infections were allocated randomly to two treatment groups. Seven horses in Group 1 received 2% moxidectin oral gel once at a dosage of 0.4 mg/kg bodyweight (BW), and seven horses in Group 2 were untreated controls. 14 days after treatment, all horses were necropsied and the stomach and proximal duodenum harvested from each. Bot larvae were recovered, identified to species and instar, and counted. At the label dosage, moxidectin oral gel was 100 and 97.6% effective (P < 0.05) against third-instar G. nasalis and G. intestinalis, respectively. In addition to demonstrating the boticidal efficacy of moxidectin, this trial illustrated that gastroscopy/duodenoscopy is a feasible method for confirming infections with different species of bot larvae in the horse.     

Activity of closantel in the prevention of Gasterophilus and Strongylus vulgaris larval infections in equine foals and yearlings

Two controlled tests were conducted in equine foals and yearlings to determine the optimal oral dosage and the duration of activity of closantel for the prevention of Gasterophilus spp larval infections. Additional data were collected on the activity of closantel against Strongylus vulgaris larval infections. In experiment 1, 12 foals and 12 yearlings were equally allocated to 4 experimental groups, and were given oral treatments with closantel at dosages of 0 (nontreated controls), 2, 5, or 8 mg/kg of body weight every 2 months during bot season. The foals and yearlings were allowed to graze on open pasture throughout the experiment to provide a natural source for bot and helminth infections. All animals were euthanatized and necropsied 6 weeks after the final treatment. Closantel was highly effective (98.6% to 100%) at all doses in preventing Gasterophilus spp larval infections in the foals, but only the 8 mg/kg dose had significant (P less than 0.05) activity (99.7%) in the yearlings. This dose also significantly reduced the numbers of 4th-stage and immature adult S vulgaris (86.0%) in the mesenteric arteries as compared with nontreated controls. In experiment 2, 9 foals and 9 yearlings received a single oral treatment of 8 mg of closantel/kg of body weight; 3 foals and 3 yearlings were kept as nontreated controls. Groups of 6 treated (3 foals, 3 yearlings) and 2 control (1 foal, 1 yearling) animals were euthanatized and necropsied 1, 2, and 3 months after treatment. Closantel remained effective for 2 months in preventing infections of G intestinalis larvae in these foals and yearlings. Clinical signs of toxicosis were not observed in the treated animals of either study.     

Efficacy of ivermectin against experimental and natural infections of Gasterophilus spp in ponies

Antiparasitic efficacy of ivermectin against migrating Gasterophilus intestinalis was evaluated in 36 treated and 24 nontreated (n = 12) or vehicle-treated (n = 12) ponies experimentally and naturally infected with G intestinalis and naturally infected with G nasalis. Each pony was experimentally infected with 500 G intestinalis 1st instars in 2 divided doses on days -14 and -7 before treatment. On day 0, ivermectin was administered at the rate of 200 micrograms/kg of body weight by IV (n = 12) or IM injection (n = 12) or given as an oral paste (n = 12). Ponies were euthanatized and necropsied 21 days after treatment. In each nontreated or vehicle-treated pony, late 1st-, 1st- to 2nd- instar molt, and early 2nd-instars of G intestinalis were found in the mouth, and 2nd- and 3rd instars of G intestinalis and 3rd instars of G nasalis were found in the stomach. Bots were not found in any ivermectin-treated pony and, thus, ivermectin was 100% effective against oral and gastric stages. Adverse reactions were not observed in ponies given ivermectin by IM injection or orally, but 1 pony given the vehicle IV and 1 pony given ivermectin (in the vehicle) IV had an anaphylactic reaction, resulting in death of the ivermectin-treated pony. It was speculated that the adverse reaction was caused by histamines released in response to vehicle components given by IV injection.